NEWS

Ingenuity Systems extends software agreement with GlaxoSmithKline

Ingenuity Systems has extended and expanded its existing license agreement with GlaxoSmithKline for access to Ingenuity Pathways Analysis (IPA) software. 

 

The new agreement enables GSK to provide enterprise-wide IPA access to researchers for rapid assessment of the signalling and metabolic pathways, molecular networks, and biological processes that are most significant to disease targets.  In addition, GSK will also use Ingenuity's content and proprietary algorithms.

 

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe looks at the latest simulation techniques used in the design of industrial and commercial vehicles

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers